Department of Psychiatry & Psychology Grand Rounds/#2016R703-B

Wednesday, September 13, 2017

12:00-1:00 pm, Gonda 5-104 Leighton Lecture Hall

Lunch will be served on a first come basis

VIDEO ACCESS

MAYO STAFF:  Access this pre-recorded session on the Video Exchange website.
 

RELEASE:  September 13, 2017
EXPIRATION:  December 31, 2018 (Credit is not available after this expiration date)

Presenter: Victor Karpyak, M.D., Ph.D.
TITLE:  Personalizing Treatment for Alcohol Use Disorders:  From Pharmacogenetics to Pharmacogenomics to Multi-omics

Dr. Victor M. Karpyak, M.D., Ph.D. is a Medical Director of the Intensive Addiction Treatment Program and Director of Mayo Clinic Addiction Services in Rochester, MN. He is a Consultant in the Department of Psychiatry and Psychology and Associate Professor of Psychiatry at the Mayo Clinic College of Medicine. His research interests are focused on discovery of genomic markers associated with alcohol use disorders and pharmacogenomics of treatment response.

Learning Objectives

1. Identify problems casued by Alcohol Use Disorders (AUD)
2. Define challenges in AUD treatment selection.
3. Recognize the role of treatment response biomarker discovery in personalized treatment.
4. Describe the role of pharmacogenetic, pharmacogenomic and multi-omic approaches as steps towards development of scientific basis for treatment of patients with AUD.

Accreditation/Credit Statements

• Mayo Clinic College of Medicine and Science is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

• Mayo Clinic College of Medicine and Science designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

NEW in 2017 !!!

All participants MUST complete the evaluation in order to get CME or APA Credit. 

• Login at ce.mayo.edu and go to My Account, My Courses, Registered Courses, click Session title and START. 
• Participate in the quiz.  Participants must pass by a minimum of 80%, 1 re-take is allowed.  Quizzes will have between 2-5 questions.
• Complete the evaluation

TRANSCRIPT:
This credit will appear on your Transcript for permanent record.  To access your transcript, visit My Account, My Activities, RSS Transcript

Disclosure Summary

As a provider accredited by ACCME, Mayo Clinic College of Medicine and Science  (Mayo Clinic School of Continuous Professional Development), must ensure balance, independence, objectivity and scientific rigor in its educational activities.   Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity.  Safeguards against commercial bias have been put in place.  Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation.  Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentation.

Listed below are individuals with control of the content of this program who have disclosed…

Relevant financial relationship(s) with industry:  

Mark Frye, M.D.   

Grant Support:  AssureRx, Janssen R&D, Myriad, Pfizer

Consultant:  Janssen R&D, Mitsubishi Tanabe Pharma Corp., Myriad Genetics, Sunovion, Supernus Pharmaceuticals, Teva Pharmaceuticals, Neuralstem, Inc.

CME/Travel:   American Physician Institute, CME Outfitters

No relevant financial relationship(s) with industry:
Kriti Gandhi, M.D., Allison Holgerson, Ph.D., Matej Markota, M.D., Charlene Nelson, Reem Shafi, M.B.B.S., Laura Suarez, M.D.

Speaker:  Victor Karpyak, M.D., Ph.D.

References to off-label usage(s) of pharmaceuticals or instruments in their presentation:  None